Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimizing Radiographic Contrast Administration During Coronary Angiography Using a Novel Contrast Reduction System: A Multicenter Observational Study of the DyeVert™ Plus Contrast Reduction System

NCT03715452 is registered in ClinicalTrials.gov with Osprey Medical, Inc as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03715452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimizing Radiographic Contrast Administration During Coronary Angiography Using a Novel Contrast Reduction System: A Multicenter Observational Study of the DyeVert™ Plus Contrast Reduction System
Lead sponsor
Osprey Medical, Inc
Phase
Observational
Overall status
Completed
Start date
July 1, 2017
Completion date
March 30, 2018
Enrollment
114 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease